• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳腺癌细胞MCF-7中LIV-1与E-钙黏蛋白表达的一致性相关性

Concordant correlation of LIV-1 and E-cadherin expression in human breast cancer cell MCF-7.

作者信息

Shen Hui, Qin Haihong, Guo Junsheng

机构信息

Department of Military Hygiene, Second Military Medical University, Shanghai 200433, PR China.

出版信息

Mol Biol Rep. 2009 Apr;36(4):653-9. doi: 10.1007/s11033-008-9225-4. Epub 2008 Mar 11.

DOI:10.1007/s11033-008-9225-4
PMID:18330719
Abstract

The recent report highlighted a significant association between signal transducer and activator of transcription 3 (STAT3) and Snail and LIV-1 (SLC39A6 or ZIP6), the breast cancer-associated protein that belongs to a new subfamily of zinc transporters. LIV-1 is a downstream target of STAT3, both in zebrafish and mammalian cells and provides control over epithelial-mesenchymal transition (EMT). Crucially, these observations link LIV-1, previously demonstrated to be associated with lymph node metastasis in breast cancer, to genes with a proven role in development. A putative role of LIV-1 as a regulator of E-cadherin that modulates the cell-cell adhesion is thus inferred. In present study, the correlation of LIV-1 and E-cadherin expression in human breast cancer cell MCF-7 and the effect of LIV-1 expression on the cell growth were assessed to explore the possible mechanisms associated with this observation in breast cancer. It was shown that the silencing of LIV-1 would induce the down-expression of E-cadherin. There was opposite results if the cells were overexpressed with LIV-1. In addition, the results showed that promotion effect after silencing of LIV-1 and inhibition effect after overexpression of LIV-1 in transfected cells. To our knowledge, this is the first evidence that the expression of E-cadherin could be regulated by the zinc transporter LIV-1. The results suggest that there is an association of LIV-1 expression with less aggressive tumors due to high E-cadherin expression because of high LIV-1 expression. LIV-1 may be a regulator of E-cadherin.

摘要

最近的一份报告强调了信号转导和转录激活因子3(STAT3)与Snail和LIV-1(SLC39A6或ZIP6)之间的显著关联,LIV-1是一种与乳腺癌相关的蛋白质,属于锌转运蛋白新亚家族。在斑马鱼和哺乳动物细胞中,LIV-1都是STAT3的下游靶点,并对上皮-间质转化(EMT)起控制作用。至关重要的是,这些观察结果将先前已证明与乳腺癌淋巴结转移相关的LIV-1与在发育过程中具有已证实作用的基因联系起来。因此推断LIV-1作为E-钙黏蛋白调节剂的假定作用,该调节剂可调节细胞间黏附。在本研究中,评估了人乳腺癌细胞MCF-7中LIV-1和E-钙黏蛋白表达的相关性以及LIV-1表达对细胞生长的影响,以探索与乳腺癌中这一观察结果相关的可能机制。结果表明,LIV-1沉默会诱导E-钙黏蛋白的表达下调。如果细胞过表达LIV-1,则结果相反。此外,结果表明,转染细胞中LIV-1沉默后有促进作用,过表达LIV-1后有抑制作用。据我们所知,这是E-钙黏蛋白表达可由锌转运蛋白LIV-1调节的首个证据。结果表明,由于LIV-1高表达导致E-钙黏蛋白高表达,LIV-1表达与侵袭性较小的肿瘤有关。LIV-1可能是E-钙黏蛋白的调节剂。

相似文献

1
Concordant correlation of LIV-1 and E-cadherin expression in human breast cancer cell MCF-7.人乳腺癌细胞MCF-7中LIV-1与E-钙黏蛋白表达的一致性相关性
Mol Biol Rep. 2009 Apr;36(4):653-9. doi: 10.1007/s11033-008-9225-4. Epub 2008 Mar 11.
2
A mechanism for epithelial-mesenchymal transition and anoikis resistance in breast cancer triggered by zinc channel ZIP6 and STAT3 (signal transducer and activator of transcription 3).锌通道 ZIP6 和 STAT3(信号转导和转录激活因子 3)触发的乳腺癌上皮-间充质转化和失巢凋亡抵抗的机制。
Biochem J. 2013 Oct 15;455(2):229-37. doi: 10.1042/BJ20130483.
3
LIV-1 enhances the aggressive phenotype through the induction of epithelial to mesenchymal transition in human pancreatic carcinoma cells.LIV-1通过诱导人胰腺癌细胞发生上皮-间质转化来增强侵袭性表型。
Int J Oncol. 2009 Oct;35(4):813-21. doi: 10.3892/ijo_00000394.
4
LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling.LIV-1 通过 HB-EGF 的脱落和 EGFR 介导的 ERK 信号促进前列腺癌上皮间质转化和转移。
PLoS One. 2011;6(11):e27720. doi: 10.1371/journal.pone.0027720. Epub 2011 Nov 16.
5
Negative correlation of LIV-1 and E-cadherin expression in hepatocellular carcinoma cells.肝癌细胞中 LIV-1 和 E-钙黏蛋白表达呈负相关。
PLoS One. 2013;8(2):e56542. doi: 10.1371/journal.pone.0056542. Epub 2013 Feb 20.
6
Zinc and cancer: implications for LIV-1 in breast cancer.锌与癌症:LIV-1 在乳腺癌中的作用。
Nutrients. 2012 Jul;4(7):648-75. doi: 10.3390/nu4070648. Epub 2012 Jul 4.
7
Recombinant Expression of Zinc Transporter SLC39A6 and Its Functional Antibody Production.锌转运蛋白SLC39A6的重组表达及其功能性抗体的制备。
Monoclon Antib Immunodiagn Immunother. 2019 Apr;38(2):70-74. doi: 10.1089/mab.2018.0045.
8
The zinc transporter LIV-1 is a novel regulator of stemness in pancreatic cancer cells.锌转运蛋白LIV-1是胰腺癌细胞干性的新型调节因子。
Scand J Gastroenterol. 2014 Feb;49(2):215-21. doi: 10.3109/00365521.2013.865075. Epub 2013 Dec 2.
9
SGN-LIV1A: a novel antibody-drug conjugate targeting LIV-1 for the treatment of metastatic breast cancer.SGN-LIV1A:一种针对 LIV-1 的新型抗体药物偶联物,用于治疗转移性乳腺癌。
Mol Cancer Ther. 2014 Dec;13(12):2991-3000. doi: 10.1158/1535-7163.MCT-13-0896. Epub 2014 Sep 24.
10
Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.磷脂酰肌醇蛋白聚糖-3可诱导人乳腺癌细胞发生间充质向上皮转化。
Oncotarget. 2016 Sep 13;7(37):60133-60154. doi: 10.18632/oncotarget.11107.

引用本文的文献

1
Cellular zinc metabolism and zinc signaling: from biological functions to diseases and therapeutic targets.细胞锌代谢和锌信号转导:从生物学功能到疾病和治疗靶点。
Signal Transduct Target Ther. 2024 Jan 3;9(1):6. doi: 10.1038/s41392-023-01679-y.
2
Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer.雌激素调节蛋白 SLC39A6:腔面乳腺癌预后良好的生物标志物。
Breast Cancer Res Treat. 2021 Oct;189(3):621-630. doi: 10.1007/s10549-021-06336-y. Epub 2021 Aug 28.
3
The role of labile Zn and Zn-transporters in the pathophysiology of mitochondria dysfunction in cardiomyocytes.

本文引用的文献

1
LIV-1 suppression inhibits HeLa cell invasion by targeting ERK1/2-Snail/Slug pathway.LIV-1抑制通过靶向ERK1/2-Snail/Slug信号通路抑制HeLa细胞侵袭。
Biochem Biophys Res Commun. 2007 Nov 9;363(1):82-8. doi: 10.1016/j.bbrc.2007.08.127. Epub 2007 Aug 30.
2
Levels of zinc, selenium, calcium, and iron in benign breast tissue and risk of subsequent breast cancer.良性乳腺组织中锌、硒、钙和铁的水平与后续患乳腺癌的风险
Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1682-5. doi: 10.1158/1055-9965.EPI-07-0187.
3
The emerging role of the LIV-1 subfamily of zinc transporters in breast cancer.
不稳定锌和锌转运体在心肌细胞线粒体功能障碍发病机制中的作用。
Mol Cell Biochem. 2021 Feb;476(2):971-989. doi: 10.1007/s11010-020-03964-8. Epub 2020 Nov 22.
4
Growth Modulatory Role of Zinc in Prostate Cancer and Application to Cancer Therapeutics.锌在前列腺癌中的生长调节作用及其在癌症治疗中的应用。
Int J Mol Sci. 2020 Apr 23;21(8):2991. doi: 10.3390/ijms21082991.
5
Subtype-specific accumulation of intracellular zinc pools is associated with the malignant phenotype in breast cancer.细胞内锌池的亚型特异性积累与乳腺癌的恶性表型相关。
Mol Cancer. 2016 Jan 5;15:2. doi: 10.1186/s12943-015-0486-y.
6
An emerging role of the cellular prion protein as a modulator of a morphogenetic program underlying epithelial-to-mesenchymal transition.细胞朊病毒蛋白作为一种调节上皮-间充质转化的形态发生程序的调节剂的新兴作用。
Front Cell Dev Biol. 2014 Sep 18;2:53. doi: 10.3389/fcell.2014.00053. eCollection 2014.
7
A mechanism for epithelial-mesenchymal transition and anoikis resistance in breast cancer triggered by zinc channel ZIP6 and STAT3 (signal transducer and activator of transcription 3).锌通道 ZIP6 和 STAT3(信号转导和转录激活因子 3)触发的乳腺癌上皮-间充质转化和失巢凋亡抵抗的机制。
Biochem J. 2013 Oct 15;455(2):229-37. doi: 10.1042/BJ20130483.
8
Negative correlation of LIV-1 and E-cadherin expression in hepatocellular carcinoma cells.肝癌细胞中 LIV-1 和 E-钙黏蛋白表达呈负相关。
PLoS One. 2013;8(2):e56542. doi: 10.1371/journal.pone.0056542. Epub 2013 Feb 20.
9
Cellular mechanisms of zinc dysregulation: a perspective on zinc homeostasis as an etiological factor in the development and progression of breast cancer.锌失衡的细胞机制:锌稳态作为乳腺癌发生和发展的病因因素的观点。
Nutrients. 2012 Aug;4(8):875-903. doi: 10.3390/nu4080875. Epub 2012 Jul 30.
10
Zinc and cancer: implications for LIV-1 in breast cancer.锌与癌症:LIV-1 在乳腺癌中的作用。
Nutrients. 2012 Jul;4(7):648-75. doi: 10.3390/nu4070648. Epub 2012 Jul 4.
锌转运蛋白LIV-1亚家族在乳腺癌中的新作用。
Mol Med. 2007 Jul-Aug;13(7-8):396-406. doi: 10.2119/2007-00040.Taylor.
4
Regulation of zinc transporters by dietary zinc supplement in breast cancer.饮食锌补充剂对乳腺癌中锌转运蛋白的调节作用
Mol Biol Rep. 2007 Dec;34(4):241-7. doi: 10.1007/s11033-007-9082-6. Epub 2007 May 1.
5
Trace elements and cancer risk: a review of the epidemiologic evidence.微量元素与癌症风险:流行病学证据综述
Cancer Causes Control. 2007 Feb;18(1):7-27. doi: 10.1007/s10552-006-0057-z.
6
The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots.前列腺癌代谢的临床相关性;锌与肿瘤抑制:梳理其中的关联
Mol Cancer. 2006 May 15;5:17. doi: 10.1186/1476-4598-5-17.
7
Importin 7 may be dispensable for human immunodeficiency virus type 1 and simian immunodeficiency virus infection of primary macrophages.输入蛋白7对于原代巨噬细胞的1型人类免疫缺陷病毒和猿猴免疫缺陷病毒感染可能并非必需。
J Virol. 2005 Sep;79(17):11541-6. doi: 10.1128/JVI.79.17.11541-11546.2005.
8
Mitochondrial function, zinc, and intermediary metabolism relationships in normal prostate and prostate cancer.正常前列腺组织和前列腺癌组织中线粒体功能、锌与中间代谢的关系
Mitochondrion. 2005 Jun;5(3):143-53. doi: 10.1016/j.mito.2005.02.001.
9
Expression levels of the putative zinc transporter LIV-1 are associated with a better outcome of breast cancer patients.假定的锌转运蛋白LIV-1的表达水平与乳腺癌患者较好的预后相关。
Int J Cancer. 2005 Dec 20;117(6):961-73. doi: 10.1002/ijc.21235.
10
Zinc transporter LIV-1: a link between cellular development and cancer progression.锌转运蛋白LIV-1:细胞发育与癌症进展之间的联系。
Trends Endocrinol Metab. 2004 Dec;15(10):461-3. doi: 10.1016/j.tem.2004.10.003.